Qiagen N.V. (QGEN)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Peer Michael Schatz
Employees:
4,684
HULSTERWEG 82, PL VENLO, NETHERLANDS 5912
31-77-35566-00

QIAGEN NV manufactures and distributes sample and assay technology products for preanalytical sample preparations. Its products include instruments, consumables, and detection technologies. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

Data derived from most recent annual or quarterly report
Market Cap 10.298 Billion Shares Outstanding227.074 Million Avg 30-day Volume 865.417 Thousand
P/E Ratio33.5109 Dividend Yield0.0 EPS1.57
Price to Revenue6.4356 Debt to Equity0.6872 EBITDA748.089 Million
Price to Book Value4.3021 Operating Margin20.660899999999998 Enterprise Value13.244 Billion
Current Ratio2.711 EPS Growth9.5 Quick Ratio1.782
1 Yr BETA 0.6332 52-week High/Low 58.0 / 41.32 Profit Margin19.2044
Operating Cash Flow Growth38.3756 Altman Z-Score3.4414 Free Cash Flow to Firm -205.551 Million
View SEC Filings from QGEN instead.

Funds Holding QGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding QGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
QIAGEN N.V. QGEN 2022-05-25 22:15:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 21:45:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 21:15:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 20:45:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 20:15:10 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 19:45:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 19:15:04 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 18:45:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 18:15:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 17:45:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 17:15:03 UTC 0.4093 0.4107 850000
QIAGEN N.V. QGEN 2022-05-25 16:45:03 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 16:15:03 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 15:45:04 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 15:15:03 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 14:45:03 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 14:15:04 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 13:45:03 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 13:15:03 UTC 0.4082 0.4118 850000
QIAGEN N.V. QGEN 2022-05-25 12:45:03 UTC 0.4082 0.4118 800000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
FundVantage Trust- Gotham Index Plus All-Cap Fund QGEN -5.0 shares, $-208.0 2020-03-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund QGEN -8600.0 shares, $-427334.0 2022-02-28 N-PORT
GMO TRUST- GMO Strategic Opportunities Allocation Fund QGEN -2526.0 shares, $-126912.26 2022-02-28 N-PORT
GMO TRUST- GMO Implementation Fund QGEN -53500.0 shares, $-2687967.54 2022-02-28 N-PORT
GMO TRUST- GMO Benchmark-Free Fund QGEN -20468.0 shares, $-1028361.11 2022-02-28 N-PORT
GMO TRUST- GMO Alternative Allocation Fund QGEN -3854.0 shares, $-193634.15 2022-02-28 N-PORT
PACE SELECT ADVISORS TRUST- PACE International Equity Investments QGEN -2356.0 shares, $-116462.37 2022-01-31 N-PORT

Elevate your investments